Assessment of


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
18 11 2020
Historique:
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 8 9 2021
Statut: epublish

Résumé

The vaginal microbiome has been connected to a wide range of health outcomes. This has led to a thriving research environment but also to the use of conflicting methodologies to study its microbial composition. Here, we systematically assessed best practices for the sequencing-based characterization of the human vaginal microbiome. As far as 16S rRNA gene sequencing is concerned, the V1-V3 region performed best

Identifiants

pubmed: 33208514
pii: 5/6/e00448-20
doi: 10.1128/mSphere.00448-20
pmc: PMC7677004
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Hugerth et al.

Références

Gynecol Endocrinol. 2018 Jun;34(6):451-455
pubmed: 29271266
J Basic Microbiol. 2018 Nov;58(11):987-997
pubmed: 30091475
Front Med (Lausanne). 2018 Jun 13;5:181
pubmed: 29951482
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Appl Environ Microbiol. 2014 Aug;80(16):5116-23
pubmed: 24928874
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
J Basic Microbiol. 2011 Aug;51(4):442-6
pubmed: 21298692
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
BMC Bioinformatics. 2019 Mar 25;20(1):153
pubmed: 30909888
J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
Nat Methods. 2017 Nov;14(11):1063-1071
pubmed: 28967888
Nat Commun. 2020 Feb 26;11(1):940
pubmed: 32103005
Infect Dis Obstet Gynecol. 2003;11(1):11-7
pubmed: 12839628
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Sci Rep. 2014 May 30;4:5136
pubmed: 24875844
PLoS One. 2020 Jan 16;15(1):e0227434
pubmed: 31945086
Genome Biol. 2020 Sep 10;21(1):242
pubmed: 32912225
Nat Biotechnol. 2018 Nov;36(10):996-1004
pubmed: 30148503
PLoS One. 2012;7(6):e39315
pubmed: 22720093
J Clin Microbiol. 2010 May;48(5):1812-9
pubmed: 20305015
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Appl Environ Microbiol. 2008 Apr;74(8):2537-9
pubmed: 18296534
Microbiologyopen. 2019 Mar;8(3):e00661
pubmed: 29931836
Clin Infect Dis. 2003 Aug 1;37(3):319-25
pubmed: 12884154
Nat Commun. 2017 Oct 17;8(1):875
pubmed: 29042534
Leg Med (Tokyo). 2012 May;14(3):160-2
pubmed: 22316585
BJOG. 2020 Jan;127(2):171-180
pubmed: 31237400
Curr HIV/AIDS Rep. 2018 Feb;15(1):30-38
pubmed: 29516267
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Nucleic Acids Res. 2014 Jan;42(Database issue):D633-42
pubmed: 24288368
Curr Infect Dis Rep. 2019 Aug 1;21(9):30
pubmed: 31367983
Nat Rev Urol. 2020 Apr;17(4):232-250
pubmed: 32071434
Sci Rep. 2018 Aug 13;8(1):12034
pubmed: 30104688
BMC Microbiol. 2005 May 18;5:28
pubmed: 15904497
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Res Microbiol. 2015 Jun;166(5):440-447
pubmed: 25869222
Res Microbiol. 2017 Nov - Dec;168(9-10):845-858
pubmed: 28502874
Nat Commun. 2019 Mar 21;10(1):1305
pubmed: 30899005
Gigascience. 2020 Feb 1;9(2):
pubmed: 32052832
Appl Environ Microbiol. 2008 Apr;74(8):2461-70
pubmed: 18296538
Am J Med. 1983 Jan;74(1):14-22
pubmed: 6600371
Microbiome. 2018 Jun 28;6(1):117
pubmed: 29954448
Microbiome. 2013 Dec 02;1(1):29
pubmed: 24451163

Auteurs

Luisa W Hugerth (LW)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Marcela Pereira (M)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Yinghua Zha (Y)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Maike Seifert (M)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Vilde Kaldhusdal (V)

Department of Medicine Solna, Division of Infectious Diseases, Karolinska University Hospital, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.

Fredrik Boulund (F)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Maria C Krog (MC)

The Recurrent Pregnancy Loss Unit, Capital Region of Denmark, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark.
Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.

Zahra Bashir (Z)

The Recurrent Pregnancy Loss Unit, Capital Region of Denmark, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark.
Department of Obstetrics and Gynaecology, Holbæk Hospital, Holbæk, Denmark.

Marica Hamsten (M)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Emma Fransson (E)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Henriette Svarre-Nielsen (H)

The Recurrent Pregnancy Loss Unit, Capital Region of Denmark, Rigshospitalet and Hvidovre Hospital, Copenhagen, Denmark.
Department of Obstetrics and Gynecology, Hvidovre Hospital, Copenhagen, Denmark.

Ina Schuppe-Koistinen (I)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.

Lars Engstrand (L)

Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden lars.engstrand@ki.se.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH